Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Naoko Matsuda, Bora Lim, Xiaoping Wang & Naoto T. Ueno. (2017) Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer. Expert Opinion on Investigational Drugs 26:4, pages 463-479.
Read now
Read now
Articles from other publishers (20)
Mohd Mustafa, Kashif Abbas, Mudassir Alam, Waleem Ahmad, Moinuddin, Nazura Usmani, Shahid Ali Siddiqui & Safia Habib. (2023) Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC). Molecular and Cellular Biochemistry.
Crossref
Crossref
Paola Ferrari, Cristian Scatena, Matteo Ghilli, Irene Bargagna, Giulia Lorenzini & Andrea Nicolini. (2022) Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC. International Journal of Molecular Sciences 23:3, pages 1665.
Crossref
Crossref
Swetha Vasudevan, Ibukun A. Adejumobi, Heba Alkhatib, Sangita Roy Chowdhury, Shira Stefansky, Ariel M. Rubinstein & Nataly Kravchenko-Balasha. (2021) Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures. Cancers 13:19, pages 5009.
Crossref
Crossref
Edoardo Crimini, Matteo Repetto, Philippe Aftimos, Andrea Botticelli, Paolo Marchetti & Giuseppe Curigliano. (2021) Precision medicine in breast cancer: From clinical trials to clinical practice. Cancer Treatment Reviews 98, pages 102223.
Crossref
Crossref
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, Jeong-Soo Park & Yeon-Sun Seong. (2021) Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. Pharmaceuticals 14:6, pages 589.
Crossref
Crossref
Hanyi Fang, Alessandra Cavaliere, Ziqi Li, Yiyun Huang & Bernadette Marquez-Nostra. (2021) Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer. Frontiers in Pharmacology 12.
Crossref
Crossref
Amal Benamrane, Brian Herry, Veacheslav Vieru, Suparna Chakraborty, Supratim Biswas, Sharon Prince, Christoph Marschner & Burgert Blom. (2021) Ionic Ruthenium and Iron Based Complexes Bearing Silver Containing Anions as a Potent New Class of Anticancer Agents. Journal of Organometallic Chemistry 934, pages 121659.
Crossref
Crossref
Hui Liu, Marcia N. Paddock, Haibin Wang, Charles J. Murphy, Renee C. Geck, Adrija J. Navarro, Gerburg M. Wulf, Olivier Elemento, Volker Haucke, Lewis C. Cantley & Alex Toker. (2020) The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer. Cancer Discovery 10:8, pages 1226-1239.
Crossref
Crossref
K.G.K. Deepak, Rahul Vempati, Ganji Purnachandra Nagaraju, Venkata Ramesh Dasari, Nagini S.D.N. Rao & Rama Rao Malla. (2020) Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacological Research 153, pages 104683.
Crossref
Crossref
Milica Nedeljković & Ana Damjanović. (2019) Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge. Cells 8:9, pages 957.
Crossref
Crossref
Anthony Ku, Conrad Chan, Sadaf Aghevlian, Zhongli Cai, David Cescon, Scott V. Bratman, Laurie Ailles, David W. Hedley & Raymond M. Reilly. (2019)
MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
99m
Tc(I) Tricarbonyl Complex
. Molecular Pharmaceutics 16:8, pages 3559-3568.
Crossref
Crossref
Qin Huang, Sai Li, Liwen Zhang, Xufang Qiao, Yanyan Zhang, Xiaoyan Zhao, Guojun Xiao & Zhubo Li. (2019) CAPE-pNO2 Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway. Frontiers in Oncology 9.
Crossref
Crossref
Ramesh Butti, Sumit Das, Vinoth Prasanna Gunasekaran, Amit Singh Yadav, Dhiraj Kumar & Gopal C. Kundu. (2018) Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Molecular Cancer 17:1.
Crossref
Crossref
Naoko Matsuda, Xiaoping Wang, Bora Lim, Savitri Krishnamurthy, Ricardo H. Alvarez, Jie S. Willey, Charla A. Parker, Juhee Song, Yu Shen, Jianhua Hu, Wenhui Wu, Nan Li, Gildy V. Babiera, James L. Murray, Banu K. Arun, Abenaa M. Brewster, James M. Reuben, Michael C. Stauder, Chad M. Barnett, Wendy A. Woodward, H. T. Carisa Le-Petross, Anthony Lucci, Sarah M. DeSnyder, Debu Tripathy, Vicente Valero & Naoto T. Ueno. (2018) Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncology 4:9, pages 1207.
Crossref
Crossref
NAOKO MATSUDA. (2018) What I Learned from Studying Abroad. Juntendo Medical Journal 64:3, pages 198-201.
Crossref
Crossref
Karima Oualla, Heba M. El-Zawahry, Banu Arun, James M. Reuben, Wendy A. Woodward, Heba Gamal El-Din, Bora Lim, Nawfel Mellas, Naoto T. Ueno & Tamer M. Fouad. (2017) Novel therapeutic strategies in the treatment of triple-negative breast cancer. Therapeutic Advances in Medical Oncology 9:7, pages 493-511.
Crossref
Crossref
Simona Camorani, Elvira Crescenzi, Matteo Gramanzini, Monica Fedele, Antonella Zannetti & Laura Cerchia. (2017) Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers. Scientific Reports 7:1.
Crossref
Crossref
Ricardo Costa, Ami N. Shah, Cesar A. Santa-Maria, Marcelo R. Cruz, Devalingam Mahalingam, Benedito A. Carneiro, Young Kwang Chae, Massimo Cristofanilli, William J. Gradishar & Francis J. Giles. (2017) Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development. Cancer Treatment Reviews 53, pages 111-119.
Crossref
Crossref
Yu-Fu Zhou, Qian Sun, Ya-Jun Zhang, Geng-Ming Wang, Bin He, Tao Qi, Yan Zhou, Xing-Wang Li, Sheng Li & Lin He. (2017) Targeted inhibition of Notch1 gene enhances the killing effects of paclitaxel on triple negative breast cancer cells. Asian Pacific Journal of Tropical Medicine 10:2, pages 179-183.
Crossref
Crossref
Denise A. Yardley, Patrick J. Ward, Brooke R. Daniel, Janice F. Eakle, Ruth E. Lamar, Cassie M. Lane & John D. Hainsworth. (2016) Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial. Clinical Breast Cancer 16:5, pages 349-355.
Crossref
Crossref